293 related articles for article (PubMed ID: 24531873)
1. Antitumor function of microRNA-122 against hepatocellular carcinoma.
Nakao K; Miyaaki H; Ichikawa T
J Gastroenterol; 2014 Apr; 49(4):589-93. PubMed ID: 24531873
[TBL] [Abstract][Full Text] [Related]
2. A novel GSK-3 beta-C/EBP alpha-miR-122-insulin-like growth factor 1 receptor regulatory circuitry in human hepatocellular carcinoma.
Zeng C; Wang R; Li D; Lin XJ; Wei QK; Yuan Y; Wang Q; Chen W; Zhuang SM
Hepatology; 2010 Nov; 52(5):1702-12. PubMed ID: 21038412
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2.
Wang B; Hsu SH; Wang X; Kutay H; Bid HK; Yu J; Ganju RK; Jacob ST; Yuneva M; Ghoshal K
Hepatology; 2014 Feb; 59(2):555-66. PubMed ID: 24038073
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of microRNA-122 by farnesoid X receptor suppresses the growth of hepatocellular carcinoma cells.
He J; Zhao K; Zheng L; Xu Z; Gong W; Chen S; Shen X; Huang G; Gao M; Zeng Y; Zhang Y; He F
Mol Cancer; 2015 Aug; 14():163. PubMed ID: 26302777
[TBL] [Abstract][Full Text] [Related]
7. An HNF4α-microRNA-194/192 signaling axis maintains hepatic cell function.
Morimoto A; Kannari M; Tsuchida Y; Sasaki S; Saito C; Matsuta T; Maeda T; Akiyama M; Nakamura T; Sakaguchi M; Nameki N; Gonzalez FJ; Inoue Y
J Biol Chem; 2017 Jun; 292(25):10574-10585. PubMed ID: 28465351
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4.
Zhou W; Zou B; Liu L; Cui K; Gao J; Yuan S; Cong N
Oncotarget; 2016 Nov; 7(45):74059-74073. PubMed ID: 27677076
[TBL] [Abstract][Full Text] [Related]
9. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus.
Yeh TS; Wang F; Chen TC; Yeh CN; Yu MC; Jan YY; Chen MF
Ann Surg; 2014 Feb; 259(2):346-54. PubMed ID: 24135722
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-503 inhibits the G1/S transition by downregulating cyclin D3 and E2F3 in hepatocellular carcinoma.
Xiao F; Zhang W; Chen L; Chen F; Xie H; Xing C; Yu X; Ding S; Chen K; Guo H; Cheng J; Zheng S; Zhou L
J Transl Med; 2013 Aug; 11():195. PubMed ID: 23967867
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-99a inhibits hepatocellular carcinoma growth and correlates with prognosis of patients with hepatocellular carcinoma.
Li D; Liu X; Lin L; Hou J; Li N; Wang C; Wang P; Zhang Q; Zhang P; Zhou W; Wang Z; Ding G; Zhuang SM; Zheng L; Tao W; Cao X
J Biol Chem; 2011 Oct; 286(42):36677-85. PubMed ID: 21878637
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus suppresses Hepatocyte Nuclear Factor 4 alpha, a key regulator of hepatocellular carcinoma.
Vallianou I; Dafou D; Vassilaki N; Mavromara P; Hadzopoulou-Cladaras M
Int J Biochem Cell Biol; 2016 Sep; 78():315-326. PubMed ID: 27477312
[TBL] [Abstract][Full Text] [Related]
13. Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development.
Xu H; He JH; Xiao ZD; Zhang QQ; Chen YQ; Zhou H; Qu LH
Hepatology; 2010 Oct; 52(4):1431-42. PubMed ID: 20842632
[TBL] [Abstract][Full Text] [Related]
14. Histone deacetylases activate hepatocyte growth factor signaling by repressing microRNA-449 in hepatocellular carcinoma cells.
Buurman R; Gürlevik E; Schäffer V; Eilers M; Sandbothe M; Kreipe H; Wilkens L; Schlegelberger B; Kühnel F; Skawran B
Gastroenterology; 2012 Sep; 143(3):811-820.e15. PubMed ID: 22641068
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
16. LXR activation potentiates sorafenib sensitivity in HCC by activating microRNA-378a transcription.
Lin Z; Xia S; Liang Y; Ji L; Pan Y; Jiang S; Wan Z; Tao L; Chen J; Lin C; Liang X; Xu J; Cai X
Theranostics; 2020; 10(19):8834-8850. PubMed ID: 32754282
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA LEF1-AS1 acts as a microRNA-10a-5p regulator to enhance MSI1 expression and promote chemoresistance in hepatocellular carcinoma cells through activating AKT signaling pathway.
Gao J; Dai C; Yu X; Yin XB; Zhou F
J Cell Biochem; 2021 Jan; 122(1):86-99. PubMed ID: 32786108
[TBL] [Abstract][Full Text] [Related]
18. Reprogramming using microRNA-302 improves drug sensitivity in hepatocellular carcinoma cells.
Koga C; Kobayashi S; Nagano H; Tomimaru Y; Hama N; Wada H; Kawamoto K; Eguchi H; Konno M; Ishii H; Umeshita K; Doki Y; Mori M
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S591-600. PubMed ID: 24740829
[TBL] [Abstract][Full Text] [Related]
19. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b.
Kim JK; Noh JH; Jung KH; Eun JW; Bae HJ; Kim MG; Chang YG; Shen Q; Park WS; Lee JY; Borlak J; Nam SW
Hepatology; 2013 Mar; 57(3):1055-67. PubMed ID: 23079745
[TBL] [Abstract][Full Text] [Related]
20. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.
Liu L; Yang X; Li NF; Lin L; Luo H
Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588
[No Abstract] [Full Text] [Related]
[Next] [New Search]